Literature DB >> 21977484

Removing barriers to insulin use.

Molly G Minze1, Kavita Dalal, Brian K Irons.   

Abstract

Patients with type 2 diabetes and their physicians are often reluctant to begin insulin therapy--despite evidence of its efficacy. Here's help in overcoming this other form of "insulin resistance."

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21977484

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  3 in total

Review 1.  Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment.

Authors:  Vivian A Fonseca; Michelle A Haggar
Journal:  Nat Rev Endocrinol       Date:  2014-02-18       Impact factor: 43.330

2.  Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region.

Authors:  Leszek Nosek; Hans-Veit Coester; Carsten Roepstorff; Henrik F Thomsen; Niels R Kristensen; Hanne Haahr; Tim Heise
Journal:  Clin Drug Investig       Date:  2014-09       Impact factor: 2.859

3.  Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.

Authors:  Meryl Brod; Suzanne Lessard Alolga; Luigi Meneghini
Journal:  Patient       Date:  2014       Impact factor: 3.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.